Accelerator
Accelerator at the Utrecht Science Park is a sustainable multi-tenant building for companies in Life Sciences. Main users will be Genmab and Merus, listed biotech companies that develop innovative therapies to treat cancer. The expected delivery of the cepezed design is early 2022.